Search
Filter Results
Displaying 531–540 of 726 for “retinal diseases”
-
DiseaseBest disease is an inherited retinal disease, which causes macular degeneration and loss of central vision, visual acuity, and color perception.
-
Jun 24, 2016
A Steady Hand in Saving Vision
Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
Aug 10, 2026
Beacon StoriesSince becoming involved with the Foundation Fighting Blindness 10 years ago, Brenda has become a dedicated leader, advocate and champion for the community. Whether welcoming someone newly diagnosed, leading the Fort Wayne Chapter or participating in a clinical trial to help advance research, Brenda has dedicated herself to creating more hope and opportunity for others.
-
Jan 26, 2026
Story Update: Seeing Through Your Disability
Beacon StoriesLance Johnson shares life with retinitis pigmentosa (RP) as a creator, father, and Foundation Fighting Blindness ambassador—advocating for awareness and advancing treatments and cures.
-
Support your clients’ charitable giving with the Foundation Fighting Blindness—where tax-smart donations fund breakthrough medical research.
-
Jun 18, 2025
José-Alain Sahel Awarded 2026 ARVO Proctor Medal for Groundbreaking Research Achievements
Research NewsDr. Sahel’s research has led to several emerging retinal disease therapies that have moved into clinical trials.
-
May 15, 2025
ARVO 2025 Highlight: J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
Research NewsDespite missing the primary endpoint, the treatment improved vision for some patients.
-
Feb 24, 2025
LCA4 Gene Therapy Restores Meaningful Vision for Blind Children
Research NewsMeiraGTx hopes to apply for marketing approval in the UK for the gene therapy.
-
There are many ways you can support the mission of the Foundation Fighting Blindness in finding treatments and cures for blinding diseases.
-
May 22, 2024
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
Research NewsThe emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease